Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Aggarwal

Showing results (201-210 of 262) with videos related to

Pageof 27
Sort By:
Rheumatology (Oxford, England)|October 24, 2021
Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathiesAlexander G S Oldroyd, Andrew B Allard, Jeffrey P Callen, et al.
Rheumatology (Oxford, England)|September 2, 2024
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Didem Saygin, et al.
Rheumatology International|December 7, 2023
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) GroupSuhrud Panchawagh, Naveen Ravichandran, Bhupen Barman, et al.
Rheumatology (Oxford, England)|October 31, 2022
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritisR Naveen, Ioannis Parodis, Mrudula Joshi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Biomarkers of rheumatoid arthritis-associated interstitial lung diseaseJuan Chen, Tracy J Doyle, Yongliang Liu, et al.
Seminars in Arthritis and Rheumatism|March 28, 2026
Prognostic significance of 1-year pulmonary function changes in inflammatory myopathy-related interstitial lung diseaseShiri Keret, Silvia Martinez Laverde, Raisa Lomanto Silva, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profilesHanna Kim, Didem Saygin, Christian Douglas, et al.
Seminars in Arthritis and Rheumatism|September 3, 2025
Item selection for the development and validation of a revised classification criteria for adult and juvenile idiopathic inflammatory myopathies: MyoROC projectDidem Saygin, Rachel Zeng, Stefanie Glaubitz, et al.
Rheumatology International|September 15, 2023
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohortSuhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, et al.
International Journal of Rheumatic Diseases|September 20, 2024
Myositis India: Early lessons from a patient support group in a resource-limited settingAnushka Aggarwal, Narendra Kumar Bagri, Chengappa Kavadichanda, et al.
Pageof 27

Showing results (201-210 of 262) with videos related to

Sort By:
Pageof 27
Rheumatology (Oxford, England)|October 24, 2021
Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathiesAlexander G S Oldroyd, Andrew B Allard, Jeffrey P Callen, et al.
Rheumatology (Oxford, England)|September 2, 2024
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Didem Saygin, et al.
Rheumatology International|December 7, 2023
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) GroupSuhrud Panchawagh, Naveen Ravichandran, Bhupen Barman, et al.
Rheumatology (Oxford, England)|October 31, 2022
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritisR Naveen, Ioannis Parodis, Mrudula Joshi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Biomarkers of rheumatoid arthritis-associated interstitial lung diseaseJuan Chen, Tracy J Doyle, Yongliang Liu, et al.
Seminars in Arthritis and Rheumatism|March 28, 2026
Prognostic significance of 1-year pulmonary function changes in inflammatory myopathy-related interstitial lung diseaseShiri Keret, Silvia Martinez Laverde, Raisa Lomanto Silva, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profilesHanna Kim, Didem Saygin, Christian Douglas, et al.
Seminars in Arthritis and Rheumatism|September 3, 2025
Item selection for the development and validation of a revised classification criteria for adult and juvenile idiopathic inflammatory myopathies: MyoROC projectDidem Saygin, Rachel Zeng, Stefanie Glaubitz, et al.
Rheumatology International|September 15, 2023
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohortSuhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, et al.
International Journal of Rheumatic Diseases|September 20, 2024
Myositis India: Early lessons from a patient support group in a resource-limited settingAnushka Aggarwal, Narendra Kumar Bagri, Chengappa Kavadichanda, et al.
Pageof 27